North America Typhoid Fever Vaccines Market Analysis and Opportunities by 2027

Historic Data: 2017-2018 | Base Year: 2019 | Forecast Period: 2020-2027

North America Typhoid Fever Vaccines Market Forecast to 2027 - Covid-19 Impact and Regional Analysis by Vaccine Type (Live Attenuated Vaccine, Capsular Polysaccharide Vaccines, Conjugate Vaccine and Others) and Route of administration (Oral and Injectable) and Country

Report Date : Nov 2020
Report Code : TIPRE00016291

Category : Life Sciences
Status : Published

Available Report Formats :
No. of Pages : 86

Page Updated: Nov 2020

Analysis Strategic Insights Market Drivers Regional Insights Report Scope Recent Developments FAQs

The North America typhoid fever vaccines market is expected to reach US$ 182.71 million in 2027 from US$ 89.84 million in 2019. The market is estimated to grow with a CAGR of 9.6% from 2020-2027.

The growth of the market is driven by the factors such as, increase in number of Americans travelling to developing countries. However, risks associated with typhoid fever vaccines likely to have negative impact on the growth of the North America Typhoid Fever Vaccines market in the coming years.

Typhoid vaccination is not recommended on a routine basis; however, it is recommended for people traveling to places where typhoid fever is common. Therefore, an increase in the number of Americans traveling outside the North American region is likely to favor the growth of the market. As per the U.S. Commerce Department’s National Travel and Tourism Office, the number of U.S. citizens traveling outside the country for business and tourism increased by 6% in 2019, reaching a total of 93 million.

Furthermore, typhoid is more prevalent in Asian countries; as per the data by National Travel & Tourism Office, in 2019, around 7,886 thousand people traveled to Asia for business and leisure, which is a 5% increase than in 2018. Thus, an increasing number of US travelers to Asian countries is likely to demand typhoid vaccination.

Furthermore, North America is witnessing the growing number of COVID-19 cases, for instance, in the United States the number of cases has been increased to 1,895,507 with 108,79 deaths reported. Additionally, Mexico and Canada cases are also growing. Due to coronavirus spreading, many cities are shutting down causing treatments and doctor’s appointment cancellation. Supply chain disruptions associated with this pandemic situation will ultimately affect the sales of products for short period. Also, stay-at-home and shelter-in-place orders have resulted in decreased outpatient pediatric visits and fewer vaccine doses were administered, leaving children at risk for vaccine-preventable diseases. Therefore, it is likely to affect typhoid fever vaccines s market owing to above mention points.

Mexico Typhoid Fever Vaccines Market Revenue and Forecast to 2027 (US$ Mn)

This FREE sample will include data analysis, ranging from market trends to estimates and forecasts.

North America Typhoid Fever Vaccines – Market Segmentation

By Vaccine Type

Live Attenuated Vaccine
Capsular Polysaccharide Vaccines
Conjugate Vaccine
Others

By Route of Administration

Oral
Injectable

By Country

US
Canada
Mexico

Company Profiles

Sanofi
GlaxoSmithKline plc
Paxvax Inc
Prokarium Ltd
Scandinavian Biopharma

North America Typhoid Fever Vaccines Report Scope

Report Attribute	Details
Market size in 2019	US$ 89.84 Million
Market Size by 2027	US$ 182.71 Million
Global CAGR (2020 - 2027)	9.6%
Historical Data	2017-2018
Forecast period	2020-2027
Segments Covered	By Vaccine Type Live Attenuated Vaccine Capsular Polysaccharide Vaccines Conjugate Vaccine By Route of administration Oral and Injectable
Regions and Countries Covered	North America US Canada Mexico
Market leaders and key company profiles	Sanofi GlaxoSmithKline plc Paxvax Inc Prokarium Ltd Scandinavian Biopharma

Research Manager

Mrinal Kerhalkar

Manager,
Market Research & Consulting

Mrinal is a seasoned research analyst with over 8 years of experience in Life Sciences Market Intelligence and Consulting. With a strategic mindset and unwavering commitment to excellence, she has built deep expertise in pharmaceutical forecasting, market opportunity assessment, and developing industry benchmarks. Her work is anchored in delivering actionable insights that empower clients to make informed strategic decisions.

Mrinal’s core strength lies in translating complex quantitative datasets into meaningful business intelligence. Her analytical acumen is instrumental in shaping go-to-market (GTM) strategies and uncovering growth opportunities across the pharmaceutical and medical device sectors. As a trusted consultant, she consistently focuses on streamlining workflow processes and establishing best practices, thereby driving innovation and operational efficiency for her clients.

What are the North America Typhoid Fever Vaccines Market report deliverables?

Historical Analysis (2 Years), Base Year, Forecast (7 Years) with CAGR
PEST and SWOT Analysis
Market Size Value / Volume - Global, Regional, Country
Industry and Competitive Landscape
Excel Dataset

Recent Reports

Testimonials

I wish to appreciate your support and the professionalism you displayed in the course of attending to my request for information regarding to infectious disease IVD market in Nigeria. I appreciate your patience, your guidance, and the fact that you were willing to offer a discount, which eventually made it possible for us to close a deal. I look forward to engaging The Insight Partners in the future, all thanks to the impression you have created in me as a result of this first encounter.

DR CHIJIOKE ONYIA MANAGING DIRECTOR, PineCrest Healthcare Ltd.

The Insight Partners delivered insightful, well-structured market research with strong domain expertise. Their team was professional and responsive throughout. The user-friendly website made accessing industry reports seamless. We highly recommend them for reliable, high-quality research services

YUKIHIKO ADACHI CEO, Deep Blue, LLC.

We worked with The Insight Partners for an important market study and forecast. They gave us clear insights into opportunities and risks, which helped shape our plans. Their research was easy to use and based on solid data. It helped us make smart, confident decisions. We highly recommend them.

PIYUSH NAGPAL Sr. Vice President, High Beam Global

I requested a report on a very specific software market and the team produced the report in a few days. The information was very relevant and well presented. I then requested some changes and additions to the report. The team was again very responsive and I got the final report in less than a week.

Jean-Herve Jenn Chairman, Future Analytica

This is the first time I have purchased a market report from The Insight Partners.While I was unsure at first, I visited their web site and felt more comfortable to take the risk and purchase a market report.I am completely satisfied with the quality of the report and customer service. I had several questions and comments with the initial report, but after a couple of dialogs over email with their analyst I believe I have a report that I can use as input to our strategic planning process.Thank you so much for taking the extra time and making this a positive experience.I will definitely recommend your service to others and you will be my first call when we need further market data.

John Suzuki President and Chief Executive Officer, Board Director, BK Technologies

The Insight Partners' SCADA System Market report is comprehensive, with valuable insights on current trends and future forecasts. The team was highly professional, responsive, and supportive throughout. We are very satisfied and highly recommend their services.

Ran Kedem Partner, Reali Technologies LTDs

Reason to Buy